MedPath

Dietary approach to stop hypertension (DASH) diet in migraine

Not Applicable
Conditions
Migraine.
Migraine without aura
G43.0
Registration Number
IRCT20121216011763N38
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
100
Inclusion Criteria

Patients who agree to participate in the study
Diagnosis of migraine by a neurologist according to ICHD-3
Aged between 20 to 50 years old
Body mass index between 18.5-30 kg/m2

Exclusion Criteria

Men with migraine
Migraine with aura
Diagnosis of other disease such as cardiovascular disease, hypertension, diabetes, liver disease, kidney disease, thyroid disorders, malignancies and other neurological problem
Pregnancy and lactation

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Migraine severity. Timepoint: At baseline and after 12 weeks. Method of measurement: Visual analogue scale.;Migraine frequency. Timepoint: At baseline and after 12 weeks. Method of measurement: Clinical examination.;Migraine duration. Timepoint: At baseline and after 12 weeks. Method of measurement: Clinical examination.;Headache impact test. Timepoint: At baseline and after 12 weeks. Method of measurement: HIT questionnaire.;Serum Nitric Oxide. Timepoint: At baseline and after 12 weeks. Method of measurement: Colorimetric method.;Serum vitamin C. Timepoint: At baseline and after 12 weeks. Method of measurement: Colorimetric method.;Total antioxidant capacity. Timepoint: At baseline and after 12 weeks. Method of measurement: Colorimetric method.;Total oxidant capacity. Timepoint: At baseline and after 12 weeks. Method of measurement: Colorimetric method.;Serum glutathion. Timepoint: At baseline and after 12 weeks. Method of measurement: Colorimetric method.
Secondary Outcome Measures
NameTimeMethod
Blood pressure. Timepoint: At baseline and after 12 weeks. Method of measurement: Sphygmomonometer.;Weight. Timepoint: At baseline and after 12 weeks. Method of measurement: Digital scale.
© Copyright 2025. All Rights Reserved by MedPath